A carregar...

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis

The potential of autologous cell‐based therapies including those using multipotent mesenchymal stromal cells (MSCs) is being investigated for multiple sclerosis (MS) and other neurological conditions. However, the phenotype of MSC in neurological diseases has not been fully characterized. We have pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: Redondo, Juliana, Sarkar, Pamela, Kemp, Kevin, Heesom, Kate J, Wilkins, Alastair, Scolding, Neil J, Rice, Claire M
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6186266/
https://ncbi.nlm.nih.gov/pubmed/30063300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0045
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!